4.5 Article

Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility

Journal

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume 31, Issue 4, Pages 870-875

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-21-0782

Keywords

-

Funding

  1. NIH [R01 CA124709, R01 CA180692, R35 CA220500]
  2. Associazione Italiana per la Ricerca sul Cancro [20757]
  3. Giulio D'Angio Endowed Chair
  4. Children's Hospital of Philadelphia Endowed Chair in Genetics Research

Ask authors/readers for more resources

Neuroblastoma is less common in African American children, but they more frequently develop the high-risk form of the disease. The study suggests that several common variants contribute to neuroblastoma risk in an ancestry-specific fashion.
Background: Neuroblastoma is rarer in African American (AA) children compared with American children of European descent. AA children affected with neuroblastoma, however, more frequently develop the high-risk form of the disease. Methods: We have genotyped an AA cohort of 629 neuroblastoma cases (254 high-risk) and 2,990 controls to investigate genetic susceptibility to neuroblastoma in AAs. Results: We confirmed the known neuroblastoma susceptibility gene BARD1 at genome-wide significance in the subset of high-risk cases. We also estimated local admixture across the autosomal genome in the AA cases and controls and detected a signal at 4q31.22 where cases show an increase in European ancestry. A region at 17p13.1 showed increased African ancestry in the subgroup of high-risk cases with respect to intermediate- and low-risk cases. Using results from our published European American (EA) genome-wide association study (GWAS), we found that a polygenic score that included all independent SNPs showed a highly significant association (P value = 1.8 x 10(-73)) and explained 19% of disease risk variance in an independent EA cohort. In contrast, the best fit polygenic score (P value = 3.2 x 10(-11)) in AAs included only 22 independent SNPs with association P value < 2.75 x 10(-6) in the EA GWAS, and explained 2% of neuroblastoma risk variance. The significance of the polygenic score dropped rapidly with inclusion of additional SNPs. Conclusions: These findings suggest that several common variants contribute to risk of neuroblastoma in an ancestry-specific fashion. Impact: This work supports the need for GWAS to be performed in populations of all races and ethnicities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available